Published in Gene Therapy Weekly, November 30th, 2006
"Although a whole tumor cell vaccine strategy based on the synergistic action of granulocyte macrophage-colonystimulating factor (GM-CSF) transduced tumor cells and CpG oligodeoxynucleotides induces potent tumor-specific immunity, such therapy is not curative in the face of large established tumors.
"The primary goal of this study was to determine if combining surgical resection of the tumor with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly